EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Case detection delay in leprosy: Testing tool reliability and measurement consistency in Ethiopia, Mozambique, and Tanzania

Ephrem Mamo iD, Robin van Wijk, Anne Schoenmakers, Kidist Bobosha, Mengistu Legesse, Thomas Hambridge, Kitesa Debelo, Fufa Daba, Nelly Mwageni, Abdoulaye Marega, Taye Letta, Ahmed Mohammed Eman und 7 weitere

PLOS Neglected Tropical Diseases · 2024

DOI: 10.1371/journal.pntd.0012314 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Ephrem Mamo und 18 weiteren Autor:innen. Beteiligte Einrichtung: Armauer Hansen Research Institute, Addis Ababa, Ethiopia. Hauptthemen laut MEDLINE: Leprosy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union awarded, Leprosy Research Initiative, European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Case detection delay (CDD) in leprosy is defined as the period between the onset of the first signs and symptoms and the time of diagnosis. A tool, consisting of a questionnaire and a detailed guide for researchers, which includes photos of typical skin signs and notes on establishing the timing of events, was developed to determine this period of delay in months in recently diagnosed leprosy patients. The aims of the study were to determine the reliability and consistency of this CDD assessment tool.

Methods

This study was conducted in Ethiopia, Mozambique and Tanzania. Two types of consistency were considered: over time (test-retest reliability) and across different researchers (interrater reliability). A CDD questionnaire was administered to 167 leprosy patients who were diagnosed within 6 months prior to their inclusion. One month later, the same or another researcher re-administered the CDD questionnaire to the same patients. Both test-retest and interrater reliability were assessed using the intraclass correlation coefficient (ICC), where a value greater than or equal to 0.7 is considered acceptable.

Results

In this study, 10 participants (6.0%) were under 15 years of age, and 56 (33.5%) were women. In the test-retest assessment, the mean CDD from the first and second interviews was 23.7 months (95% CI 14.4–34.8) and 24.0 months (95% CI 14.8–33.2), respectively. The ICC for test-retest reliability was 0.99 (95% CI 0.994–0.997). For the interrater reliability assessment, the first and second interviews revealed a mean CDD of 24.7 months (95% CI 18.2–31.1) and 24.6 months (95% CI 18.7–30.5), respectively, with an ICC of 0.90 (95% CI 0.85–0.94). A standard error of measurement of 0.46 months was found in the test-retest and 1.03 months in the interrater measurement. Most answers given by participants during the first and second interviews were matching (≥86%). Most non-matching answers were in the 0–2 month delay category (≥46%).

Conclusion

The tool, including a questionnaire to determine the CDD of newly diagnosed leprosy patients, was validated in three African countries. The test-retest and interrater measurements demonstrated that the instrument is reliable and measures consistently. The tool can be used in routine leprosy programmes as well as in research settings.

Trial registration

This trial is registered with The Netherlands Trial Register (NTR), now available via International Clinical Trial Registry Platform (ICTRP) with registration number NL7294 (NTR7503), as well as with The Pan African Clinical Trials Registry (PACTR) with registration number PACTR202303742093429 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeprosyHumansFemaleMaleTanzaniaMozambiqueEthiopiaAdultAdolescentReproducibility of ResultsSurveys and QuestionnairesYoung AdultMiddle AgedDelayed DiagnosisChildAged

Autor:innen und Institutionen

  • Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
  • Addis Ababa university, Addis Ababa, Ethiopia.
  • Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • NLR/Leprastichting, Amsterdam, The Netherlands.
  • Deutsche Lepra- und Tuberkulosehilfe e.V. Ethiopia, Addis Ababa, Ethiopia.
  • Catholic University of Health and Allied Sciences, Mwanza, United Republic of Tanzania.

ORCID-Profile: Ephrem Mamo

Förderung

  • European Union awarded
  • Leprosy Research Initiative
  • European Union

Zitieren

APA

Mamo, E., van Wijk, R., Schoenmakers, A., Bobosha, K., Legesse, M., Hambridge, T., Debelo, K., Daba, F., Mwageni, N., Marega, A., Letta, T., Eman, A. M., Fumane, B., Rassolo, H., Njako, B. F., E Mshana, S., Richardus, J. H., Kasang, C., & Mieras, L. (2024). Case detection delay in leprosy: Testing tool reliability and measurement consistency in Ethiopia, Mozambique, and Tanzania. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012314

Vancouver

Mamo E, van Wijk R, Schoenmakers A, Bobosha K, Legesse M, Hambridge T, et al. Case detection delay in leprosy: Testing tool reliability and measurement consistency in Ethiopia, Mozambique, and Tanzania. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012314

BibTeX
@article{Mamo2024,
  author = {Mamo, Ephrem and van Wijk, Robin and Schoenmakers, Anne and Bobosha, Kidist and Legesse, Mengistu and Hambridge, Thomas and Debelo, Kitesa and Daba, Fufa and Mwageni, Nelly and Marega, Abdoulaye and Letta, Taye and Eman, Ahmed Mohammed and Fumane, Banú and Rassolo, Helder and Njako, Blasdus Franz and E Mshana, Stephen and Richardus, Jan Hendrik and Kasang, Christa and Mieras, Liesbeth},
  title = {Case detection delay in leprosy: Testing tool reliability and measurement consistency in Ethiopia, Mozambique, and Tanzania},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  doi = {10.1371/journal.pntd.0012314}
}
Kostenlos starten →